HAVCR2 and Autoimmunity: Tim-3 attracted interest when it was discovered as a T-cell inhibitory receptor, and the concept was further supported by the studies showing that in vivo administration of monoclonal antibody specific to Tim-3 (mAbs) ameliorated or exacerbated disease in models of autoimmunity.